Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Hitherto unseen survival in an ALK-positive-patient withadvanced stage adult ganglioneuroblastoma treated withpersonalized medicine
Forlagets udgivne version, 65,7 KB, PDF-dokument
Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologies in cancer diagnostic and treatment.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Case Reports |
Vol/bind | 5 |
Udgave nummer | 12 |
Sider (fra-til) | 2085-2087 |
Antal sider | 3 |
ISSN | 2050-0904 |
DOI | |
Status | Udgivet - dec. 2017 |
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 196371326